Combined Anti-CD154/CTLA4Ig Costimulation Blockade-Based Therapy Induces Donor-Specific Tolerance to Vascularized Osteomyocutaneous Allografts.
Am J Transplant
; 16(7): 2030-41, 2016 07.
Article
in En
| MEDLINE
| ID: mdl-26914847
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Skin Diseases
/
Tissue Donors
/
Bone Marrow Transplantation
/
CD40 Ligand
/
Myocutaneous Flap
/
Abatacept
/
Immune Tolerance
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Am J Transplant
Journal subject:
TRANSPLANTE
Year:
2016
Document type:
Article
Affiliation country:
Taiwan
Country of publication:
United States